Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Weaning for a Weight Drug? Mom Asks About Stopping Nursing Safely

A person on an online forum asked whether anyone stopped breastfeeding before starting a weekly GLP-1 drug (the class that includes tirzepatide, brand Mounjaro, and semaglutide, brand Wegovy/Ozempic) but kept doing occasional “comfort nursing” with their baby. They’re a 26-year-old about to begin one of these medications and were told by their doctor to wean before starting. The baby is nearly seven months old and already getting some formula or solids, so full weaning is possible. The post is basically asking if short, occasional nursing after official weaning would be safe or if they really need to stop completely. GLP-1 drugs are medicines that copy a hormone your gut makes after you eat. That hormone helps control appetite and blood sugar by acting on the brain and pancreas. Semaglutide and tirzepatide are engineered versions that last a long time and are used weekly to treat diabetes and help with weight loss. They’re not the same as typical over-the-counter supplements; they’re prescription medicines that affect your hormones and metabolism. The core of the question touches on whether any of the drug would get into breast milk and reach the baby during occasional nursing. The medical guidance the poster received — to wean before starting — comes from a lack of good safety data. Clinical drug studies usually exclude pregnant or breastfeeding people, so manufacturers and doctors often recommend stopping breastfeeding because we don’t have solid numbers showing how much of these drugs pass into milk or what dose a baby would get. There aren’t robust human studies showing safety for breastfeeding infants; most advice errs on the side of caution. The post doesn’t add new data, it’s asking for personal experiences or anecdotal reports. Why this matters: new parents juggling weight, postpartum health, and caring for a baby want to know if they can have both: benefit from these effective drugs and continue bonding or soothing their infant with occasional nursing. For some people, comfort nursing is important for the baby’s sleep or emotional needs even after nutrition is primarily from formula or solids. A careful parent needs to weigh the potential benefits of starting a GLP-1 for their health against the unknowns about exposure to the infant and their own doctor’s advice. Caveats and risks: the big issue is uncertainty. We don’t have clear evidence that these drugs are safe for breastfed infants, so many providers recommend stopping breastfeeding before starting them. Potential side effects for the parent include nausea, changes in appetite, and other known drug effects; for the baby, unknown exposure could be a concern. If you’re considering this, discuss timing with your clinician: some suggest pumping and dumping for a specified period or delaying the first dose until fully weaned. Never rely on forum anecdotes as proof of safety. If you want to continue occasional comfort nursing, raise that explicitly with your healthcare team so they can discuss risks, alternatives, and timing based on the specific medication and your situation. Bottom line: doctors often tell new parents to stop breastfeeding before starting GLP-1 drugs because safety data are limited; occasional comfort nursing is understandable, but you should get individualized medical advice rather than relying on online anecdotes.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE